HOOKIPA Pharma Files Q1 2025 10-Q
Ticker: HOOK · Form: 10-Q · Filed: May 15, 2025 · CIK: 1760542
| Field | Detail |
|---|---|
| Company | Hookipa Pharma Inc. (HOOK) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
HOOKIPA Pharma's Q1 2025 10-Q is in: financials and operations updated.
AI Summary
HOOKIPA Pharma Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information and business operations for the first quarter of 2025. Specific financial figures and operational updates are provided within the report, which is available on their website.
Why It Matters
This filing provides investors with an update on HOOKIPA Pharma's financial health and operational progress during the first quarter of 2025, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, HOOKIPA Pharma is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 20250331 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial information is reported.)
- 20250515 — Filing Date (The date the 10-Q report was officially submitted to the SEC.)
Key Players & Entities
- HOOKIPA Pharma Inc. (company) — Filer of the 10-Q report
- 20250331 (date) — End of the reporting period
- 20250515 (date) — Date of filing
- 001-38869 (other) — SEC file number
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 15, 2025.
What is HOOKIPA Pharma Inc.'s SEC file number?
HOOKIPA Pharma Inc.'s SEC file number is 001-38869.
What is the fiscal year end for HOOKIPA Pharma Inc.?
HOOKIPA Pharma Inc.'s fiscal year ends on December 31.
Where is HOOKIPA Pharma Inc. headquartered?
HOOKIPA Pharma Inc.'s business address is listed as 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240, NEW YORK, NY 10118.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding HOOKIPA Pharma Inc. (HOOK).